Chinese patent medicine is expected to enter the mainstream pharmaceutical market in the United States

Shanghai Modern Chinese Medicine Co., Ltd recently announced in China that its innovative Chinese medicine "Fuzheng Huayu Capsule (tablet)" has successfully completed clinical trials in the United States This study, based on the highest standard in the United States, verified the efficacy, safety and effectiveness of Fuzheng Huayu Capsule (tablet) in the treatment of chronic hepatitis C liver fibrosis It is reported that this is the first Chinese patent medicine in the field of liver disease in the United States for clinical trials It is reported that the three generations of experts of Shanghai University of traditional Chinese medicine, after more than 20 years of research, independently developed and produced Fuzheng Huayu Capsule (tablet) by using modern technology and methods, which has been proved to be effective in the treatment of liver fibrosis by more than 50000 cases in China, and has won the second prize of national science and technology progress In order to promote the internationalization of traditional Chinese medicine, with the support of the national science and technology support plan of the 11th Five Year Plan and the "international science and technology cooperation and exchange program" of the Ministry of science and technology, it is expected to become the first Chinese patent medicine in the field of liver disease that has passed the clinical trials in the United States, and also the first compound traditional Chinese medicine that has been approved to enter the mainstream medical market in the United States Prior to that, it has completed domestic and phase clinical trials and successfully listed in the mainland and Hong Kong Professor Liu Ping, vice president of Shanghai University of traditional Chinese medicine and one of the developers of Fuzheng Huayu formula, said that traditional Chinese medicine has the advantage of multiple targets in clinical treatment However, problems such as backward quality standards, unclear effective ingredients and mechanism of action hinder the integration of traditional Chinese medicine with the world The success of Fuzheng Huayu Capsule (tablet) represents that the safety, effectiveness and quality control of Chinese patent medicine have been recognized by the most stringent drug regulatory agency in the world.